Subacute (de Quervain's) Thyroiditis - Pain Persisting During Steroid Taper

Why Pain Persists During Tapering

Step-by-Step Management of Relapse During Taper

Step 1 - Increase the Steroid Dose Back Up

• Increase prednisone to the last dose that controlled the pain (typically back up to 20-30 mg or whatever dose previously provided relief)
• Do NOT jump back to 60 mg unless symptoms are truly severe - the evidence favors lower initial doses and re-escalation should be proportionate to symptoms

Harrison's 22e: "If a relapse occurs during glucocorticoid withdrawal, the dosage should be increased and then withdrawn more gradually."

Step 2 - Extend and Slow the Taper

• Once pain is controlled again, taper over 8-12 weeks minimum (not 6 weeks)
• Suggested taper schedule after re-escalation:
  • Reduce by 5 mg every 1-2 weeks, not 10 mg/week
  • Monitor ESR and symptoms with each step - do NOT reduce dose if ESR is still significantly elevated
  • A rising or still-elevated ESR is your signal to hold the taper

Step 3 - Add/Optimize Baseline Analgesia (Bridging)

• NSAIDs (e.g., ibuprofen 400-600 mg TID or naproxen 500 mg BID) should be used as background analgesia throughout the taper
• This allows the steroid dose to be reduced while still managing residual inflammation
• Add a proton pump inhibitor (e.g., omeprazole 20 mg OD) when combining steroids with NSAIDs - this is mandatory

Step 4 - Monitor Thyroid Function Every 2-4 Weeks

• Check TSH and free T4 every 2-4 weeks throughout the course
• At the time of relapse, recheck:
  • TSH, free T4
  • ESR / CRP (guides taper speed - ESR is your biomarker)
  • The patient's current phase: are they still thyrotoxic, or already hypothyroid?

Step 5 - Manage Phase-Specific Complications

• If still in the thyrotoxic phase: use a beta-blocker (propranolol 10-40 mg TID or atenolol 25-50 mg OD) for palpitations, tremor, sweating - antithyroid drugs (methimazole, PTU) have NO role
• If entering the hypothyroid phase: consider low-dose levothyroxine (50-75 mcg/day) if symptomatic - use the lowest dose needed to allow TSH-mediated recovery

Consider Intrathyroidal Steroid Injection (If Oral Relapse)

• A 2022 systematic review [PMID: 35966510] highlighted that intrathyroidal glucocorticoid injection (e.g., methylprednisolone injected directly into the thyroid lobes under ultrasound guidance) is potentially faster-acting and safer than continued oral prednisone, with fewer systemic side effects
• This is an option especially when the patient has had multiple relapses or cannot tolerate escalating oral steroids
• Typically done by an endocrinologist under ultrasound guidance: 10-40 mg methylprednisolone per lobe

Prognosis Expectation

• Most patients recover fully within 6-12 months total
• A small percentage (roughly 15%) develop permanent hypothyroidism, especially those with coincidental thyroid autoimmunity
• A prolonged course with multiple relapses occurs in a minority - reassure the patient this is self-limiting

Summary Table

• Harrison's Principles of Internal Medicine 22e (2025), Treatment: Subacute Thyroiditis, p. 3082
• Bailey and Love's Short Practice of Surgery 28e, Granulomatous Thyroiditis
• Katzung's Basic and Clinical Pharmacology 16e, Subacute Thyroiditis
• Ray I et al., "Management of Subacute Thyroiditis - A Systematic Review of Current Treatment Protocols," Int J Gen Med 2022 [PMID: 35966510]